Overview
HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)
Status:
Completed
Completed
Trial end date:
2002-10-16
2002-10-16
Target enrollment:
0
0
Participant gender:
All
All
Summary
A study to test the safety and efficacy of HYZAAR as compared to Ramipril in patients with type 2 diabetes mellitus (high blood sugar) and hypertension (high blood pressure).Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Hydrochlorothiazide
Losartan
Ramipril
Criteria
Inclusion Criteria:- Patient is at least 18 years old, has been diagnosed with type 2 diabetes mellitus
Exclusion Criteria:
- Patient has renal disease, malignant hypertension, uncontrolled type 2 diabetes
mellitus, history of stroke, TIA (Transient Ischemic Attacks) , or heart disease